Experimental graft-versus-host disease treatment equivalent to standard care ... HealthCanal.com The combination of two immunosuppressive compounds – tacrolimus plus sirolimus – did not provide a statistically significant, GVHD -free survival benefit over the long-used standard of care, tacrolimus plus methotrexate, said researchers from Dana ... |
